Paula Boultbee

Oncology Market Specialist

Paula Boultbee is nothing short of an impassioned expert in the field of oncology, initially treating and assisting patients as an Oncology RN and later realizing a career as a senior executive leading marketing initiatives for numerous breakthrough cancer treatments – she has dedicated her entire professional life to oncology.

A multi-disciplined specialist, Paula’s extensive skillset spans global commercialization planning, pre-launch preparation, major launch initiatives for first-in-class agents, and patient advocacy.

Her list of notable accomplishments in the biopharma sector includes introducing and supporting brands like Imbruvica (ibrutinib), Glivec/Gleevec (imatinib), Aranesp (darbopoetin), Camptosar (irinotecan), and Vectibix (panitumumab). In addition, she has held top-tier positions, as well as consulted, for major companies including Pharmacia (Pfizer), Novartis, Amgen, Proteolix (Onyx), Dendreon, Incyte, and Pharmacyclics, among others.

Paula’s extensive knowledge of oncology, and hands-on attention to organizational detail has made a demonstrable impact on the success of many top-of-mind brands. As an oncology market specialist working with FreshBlood, Paula is available to organize, strategize and lead a team through the myriad obstacles and opportunities that define today’s complex healthcare marketplace.

Paula serves on the Board of Directors of the Max Foundation – a global health non-profit organization that believes all people living with cancer have the right to access the best treatment and support. By partnering with industry, non-governmental agencies, health care providers, and national cancer patient organizations, Paula’s work through the Max Foundation is helping people in more than 100 countries.